SYLDESTA

Welcome to the Brand page for “SYLDESTA”, which is offered here for Human pharmaceutical preparations for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases;.

Its status is currently believed to be active. Its class is unavailable. “SYLDESTA” is believed to be currently owned by “Johnson & Johnson”.

Owner:
JOHNSON & JOHNSON
Owner Details
Description:
Human pharmaceutical preparations for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases;
Categories: HUMAN PHARMACEUTICAL PREPARATIONS